The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online 17 July 2000.
This Article
Right arrow Full Text (PDF, 6K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
© The Rockefeller University Press, 0022-1007/2000/7/311/ $5.00
The Journal of Experimental Medicine, Volume 192, Number 2, July 17, 2000 311-312

Correction

© 2000 The Rockefeller University Press

The authors regret an erroneous statement in the legend and text for Fig. 2 A. Their correction follows.

The CD11b promoter used in the construct described in Fig. 2 A was of human, not mouse, origin as described in reference 24. This does not affect the conclusions of the article, as human CD11b promoter drives myeloid protein expression. The human CD89 transgene expression, driven by the CD11b promoter in this study, was on mouse monocyte/macrophages as verified by staining with anti–mac-1 mAb.





This Article
Right arrow Full Text (PDF, 6K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS